Practice Clinical updates

Management of patients after primary percutaneous coronary intervention for myocardial infarction

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3237 (Published 20 July 2017) Cite this as: BMJ 2017;358:j3237

Reply to Dr Nicholas J Sharvill

Dear Sir,
PPIs greatly increase mortality, much more than bleeding from dual antiplatelet therapy does!
MI recovering patients would probably reject such "gastro protection medication" recommendations, if presented with this new evidence.
Reference
http://bmjopen.bmj.com/content/7/6/e015735

Competing interests: No competing interests

24 July 2017
Stavros Saripanidis
Consultant in Obstetrics and Gynaecology
Kalamaria, Thessaloniki, Greece